Potential public health impact of a Neisseria meningitidis A, B, C, W, and Y pentavalent vaccine in the United States
Open Access
- 22 February 2021
- journal article
- research article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 134 (4) , 341-348
Abstract
Globally, 5 serogroups (A, B, C, W, and Y) cause the majority of invasive meningococcal disease (IMD). Vaccines targeting these serogroups are currently part of the US adolescent immunization platf...Keywords
Funding Information
- Pfizer Inc
This publication has 43 references indexed in Scilit:
- Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young AdultsThe Pediatric Infectious Disease Journal, 2015
- Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015MMWR. Morbidity and Mortality Weekly Report, 2015
- Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy AdolescentsJournal of the Pediatric Infectious Diseases Society, 2015
- Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trialThe Lancet, 2014
- Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and WalesClinical Infectious Diseases, 2014
- Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling studyBMJ, 2014
- Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled studyBMC Infectious Diseases, 2013
- A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adultsVaccine, 2013
- The natural history of meningococcal carriage and diseaseEpidemiology and Infection, 2005
- HUMAN IMMUNITY TO THE MENINGOCOCCUSJournal of Experimental Medicine, 1969